Cephalexin and Red cell distribution width increased - a phase IV clinical study of FDA data

Summary:

We study 27,270 people who have side effects when taking Cephalexin. Red cell distribution width increased is found, especially among people who are male, 60+ old, have been taking the drug for 1 - 6 months, also take Aspirin and have Pain.

The phase IV clinical study analyzes which people take Cephalexin and have Red cell distribution width increased. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

27,270 people reported to have side effects when taking Cephalexin.
Among them, 21 people (0.08%) have Red cell distribution width increased.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is used in infection. Currently, eHealthMe is studying from 28,659 Cephalexin users.

What is Red cell distribution width increased?

Red cell distribution width increased is found to be associated with 1,222 drugs and 599 conditions by eHealthMe. Currently, we are studying 5,064 people who have Red cell distribution width increased.

Number of Cephalexin and Red cell distribution width increased reports submitted per year:

Could Cephalexin cause Red cell distribution width increased?

Time on Cephalexin when people have Red cell distribution width increased *:

Gender of people who have Red cell distribution width increased when taking Cephalexin *:

female: 50 %
male: 50 %

Age of people who have Red cell distribution width increased when taking Cephalexin *:

Common drugs people take besides Cephalexin *:

Common side effects people have besides Red cell distribution width increased *:

Haemoglobin Decreased: 11 people, 52.38%
Haematocrit Decreased: 9 people, 42.86%
Red Blood Cell Count Decreased: 9 people, 42.86%
Blood Glucose Increased: 9 people, 42.86%
Weakness: 8 people, 38.10%
Thrombocytopenia (decrease of platelets in blood): 7 people, 33.33%
Blood Urea Increased: 6 people, 28.57%
Diarrhea: 6 people, 28.57%
Blood Chloride Decreased: 6 people, 28.57%
Pain: 6 people, 28.57%

Common conditions people have *:

Pain: 5 people, 23.81%
High Blood Cholesterol: 3 people, 14.29%
Breast Cancer: 3 people, 14.29%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 14.29%
Sleep Disorder: 2 people, 9.52%
Asthma: 2 people, 9.52%
Stress And Anxiety: 2 people, 9.52%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 9.52%
Essential Thrombocythaemia (chronic blood cancer): 2 people, 9.52%
Diabetes: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and have Red cell distribution width increased?

Check whether Red cell distribution width increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

Related studies

Cephalexin side effects by duration, gender and age:

Cephalexin side effects (28,659 reports)

Red cell distribution width increased treatments and more:

Red cell distribution width increased (5,064 reports)

Common drugs associated with Red cell distribution width increased:

All the drugs that are associated with Red cell distribution width increased:

Red cell distribution width increased (1,222 drugs)

Common conditions associated with Red cell distribution width increased:

Relapsing-remitting multiple sclerosis: 276 reports
Rheumatoid arthritis: 270 reports
Multiple sclerosis: 226 reports
Pain: 212 reports
Breast cancer: 209 reports
High blood pressure: 187 reports
Schizophrenia: 182 reports
Asthma: 160 reports

All the conditions that are associated with Red cell distribution width increased:

Red cell distribution width increased (599 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cephalexin (the active ingredients of Cephalexin) and Cephalexin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.